R
Raluca Pais
Researcher at University of Paris
Publications - 63
Citations - 2882
Raluca Pais is an academic researcher from University of Paris. The author has contributed to research in topics: Fatty liver & Steatohepatitis. The author has an hindex of 20, co-authored 52 publications receiving 2139 citations. Previous affiliations of Raluca Pais include Institute of Chartered Accountants of Nigeria & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
Raluca Pais,Frédéric Charlotte,Larissa Fedchuk,Pierre Bedossa,Pascal Lebray,Thierry Poynard,Vlad Ratziu +6 more
TL;DR: A substantial proportion of patients with NAFL can progress towards well-defined NASH with bridging fibrosis, especially if metabolic risk factors deteriorate, and current monitoring practices of these patients should be revised.
Journal ArticleDOI
From NAFLD in clinical practice to answers from guidelines
Fabio Nascimbeni,Raluca Pais,Stefano Bellentani,Christopher P. Day,V. Ratziu,Paola Loria,Amedeo Lonardo +6 more
TL;DR: This review of the literature consists of three sections: papers concerning non-alcoholic fatty liver disease awareness among the general population, general practitioners, and liver and non-liver specialists, and clinical practice guidelines issued by International and National Hepatological Scientific Societies.
Journal ArticleDOI
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
TL;DR: Several steatosis biomarkers are available with limited independent validation and some are suitable for clinical use while others are inappropriate for clinical practice.
Journal ArticleDOI
NAFLD and liver transplantation: Current burden and expected challenges
Raluca Pais,Raluca Pais,A. Sidney Barritt,Yvon Calmus,Yvon Calmus,Olivier Scatton,Thomas M. Runge,Pascal Lebray,Thierry Poynard,Thierry Poynard,Vlad Ratziu,Vlad Ratziu,Filomena Conti,Filomena Conti +13 more
TL;DR: The multifaceted impact of NAFLD on liver transplantation is reviewed and the alternative management and therapeutic options to improve the long-term outcomes with particular emphasis on the correction and control of metabolic comorbidities are discussed.
Journal ArticleDOI
Metabolic syndrome and risk of subsequent colorectal cancer
TL;DR: Understanding the pathological mechanism that links metabolic syndrome and its components to carcinogenesis has a major clinical significance and may have profound health benefits on a number of diseases including cancer, which represents a major cause of mortality and morbidity in the authors' societies.